Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB321 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human VEGF R1/Flt-1 Monoclonal Antibody (Clone 49560)
- Antibody type
- Monoclonal
- Antigen
- S. frugiperda insect ovarian cell line Sf 21-derived recombinant human VEGF R1/Flt-1
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells.
Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.
Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.
Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells.
Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Odent Grigorescu G, Rosca AM, Preda MB, Tutuianu R, Simionescu M, Burlacu A
Journal of tissue engineering and regenerative medicine 2017 Nov;11(11):3241-3252
Journal of tissue engineering and regenerative medicine 2017 Nov;11(11):3241-3252
Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.
Jarajapu YP, Hazra S, Segal M, Li Calzi S, Jadhao C, Qian K, Mitter SK, Raizada MK, Boulton ME, Grant MB
PloS one 2014;9(4):e93965
PloS one 2014;9(4):e93965
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.
Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G
Nature 2011 Jul 13;475(7355):226-30
Nature 2011 Jul 13;475(7355):226-30
Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR, Eberlein C, Shibuya M, Wedge SR, Barry ST
Angiogenesis 2010 Dec;13(4):337-47
Angiogenesis 2010 Dec;13(4):337-47
Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
Meissner M, Reichenbach G, Stein M, Hrgovic I, Kaufmann R, Gille J
Cancer research 2009 Mar 1;69(5):1976-84
Cancer research 2009 Mar 1;69(5):1976-84
Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
Riccioni R, Senese M, Diverio D, Riti V, Mariani G, Boe A, LoCoco F, Foà R, Peschle C, Sporn M, Testa U
Leukemia research 2008 Aug;32(8):1244-58
Leukemia research 2008 Aug;32(8):1244-58
Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.
Caldas H, Fangusaro JR, Boué DR, Holloway MP, Altura RA
Blood 2007 Feb 15;109(4):1479-89
Blood 2007 Feb 15;109(4):1479-89
Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells.
Lin YL, Liang YC, Chiang BL
Journal of leukocyte biology 2007 Dec;82(6):1473-80
Journal of leukocyte biology 2007 Dec;82(6):1473-80
Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, Petrucci E, Cedrone M, Lo-Coco F, Foà R, Peschle C, Testa U
Stem cells (Dayton, Ohio) 2007 Aug;25(8):1862-71
Stem cells (Dayton, Ohio) 2007 Aug;25(8):1862-71
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GY
European journal of clinical investigation 2003 Oct;33(10):883-90
European journal of clinical investigation 2003 Oct;33(10):883-90
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GY
European journal of clinical investigation 2003 Oct;33(10):883-90
European journal of clinical investigation 2003 Oct;33(10):883-90
No comments: Submit comment
No validations: Submit validation data